#United States #Natus Medical #Middleton #Neurodiagnostics #Holberg EEG

Natus Medical Acquires Holberg EEG

On September 30, 2025, Natus Medical Incorporated, recognized as the world’s most extensive solely dedicated neurodiagnostics company, announced a strategic advancement by acquiring the remaining minority shares of Holberg EEG. This acquisition marks a significant leap towards enhancing neurodiagnostic solutions powered by artificial intelligence (AI). Holberg EEG is notably known for its pioneering work in developing the first AI model that facilitates automatic and comprehensive clinical EEG interpretation, achieving accuracy comparable to leading medical experts.

Natus now possesses full ownership of Holberg EEG, with hopes to integrate its innovative technologies into Natus’s already comprehensive neurodiagnostics portfolio, furthering its mission to optimize brain health through advanced, accessible solutions. CEO Chris Landon expressed enthusiasm regarding this acquisition, noting it is a pivotal milestone that permits Natus to accelerate the implementation of state-of-the-art AI technologies. He highlighted that this initiative empowers healthcare professionals with faster and more accurate EEG interpretations, thereby enhancing patient outcomes across the globe.

The introduction of Holberg's AI model, known as autoSCORE, is destined to revolutionize the efficiency and diagnostic reliability that clinicians experience when interpreting complex EEG data. This is especially crucial for addressing the noticeable gaps prevalent in neurological care today. The autoSCORE AI model, which seamlessly integrates with Natus NeuroWorks® software, has already received FDA 510(k) clearance for various EEG studies, reflecting its reliability and safe usage in clinical settings.

Holberg EEG, founded in 2009, focuses on enhancing clinical outcomes through the application of AI in EEG interpretation. With its robust AI model trained on over 30,000 expertly labeled EEG recordings, Holberg brings significant expertise to the partnership. Its flagship model, autoSCORE, was first introduced to the U.S. market in August 2024, establishing it as a transformative tool that alleviates the strains on clinical resources.

Implementing the Holberg EEG’s technology with Natus’s trusted neurodiagnostic solutions holds the promise of bettering the workflows of healthcare providers and clinicians worldwide. Enhanced accuracy and improved patient care are cornerstones of this integration. The collective experience drawn from over 85 years of neurodiagnostic practice will further propel both Natus and Holberg EEG towards a shared goal: innovating AI-powered solutions for global patient wellness in neurology.

Natus Medical is esteemed by healthcare providers across the globe, recognized for supplying comprehensive solutions aimed at screening, diagnosing, and treating various brain and neural pathway disorders. The company’s offerings, which include exemplary service, field support, and educational resources, enable clinicians to elevate their standards of care, thereby enhancing patient quality of life.

Holberg EEG emerged from Haukeland University Hospital in Bergen, Norway, driven by the desire to merge structured EEG data with artificial intelligence to enhance patient care significantly. The partnership with Natus promises to transform EEG interpretation practices for years to come, pushing the boundaries of what’s possible in neurodiagnostics.

In summary, Natus’s acquisition of Holberg EEG stands as a remarkable adaptation in the ever-evolving landscape of neurodiagnostics. In combining technologies, both companies aim to elevate the standards of brain health through innovative solutions that could significantly alter the future of neurological care.